Inhibition of benzo(a)pyrene-induced carcinogenesis by vitamin C alone and by vitamin C/vitamin E and selenium/glutathione

Biological Trace Element Research

Volumn 93, Issue 1-3, 2003, Pages 201-211

  Charalabopoulos, K ^a   Karkabounas, S ^a   Charalabopoulos, A K ^a   Papalimneou, V ^a   Ioachim, E ^a   Giannakopoulos, X ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Benzo(a)pyrene; Carcinogenesis; Glutathione; Selenium; Vitamin C; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTINEOPLASTIC AGENT; ASCORBIC ACID; BENZO[A]PYRENE; BENZO[A]PYRENE DERIVATIVE; GLUTATHIONE; POLYCYCLIC AROMATIC HYDROCARBON; SELENIUM;

ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CARCINOGENESIS; CELL PROLIFERATION; CELL PROTECTION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME ACTIVITY; EXPERIMENTAL NEOPLASM; FEMALE; FIBROSARCOMA; GROWTH INHIBITION; IATROGENIC DISEASE; LIPID PEROXIDATION; MALIGNANT TRANSFORMATION; NONHUMAN; RAT; RAT STRAIN; SURVIVAL; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC AGENTS; ASCORBIC ACID; BENZOPYRENES; DRUG SYNERGISM; FEMALE; FIBROSARCOMA; GLUTATHIONE; NEOPLASMS, EXPERIMENTAL; RATS; RATS, WISTAR; SELENIUM; SURVIVAL ANALYSIS; VITAMIN E;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0041666292     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1385/BTER:93:1-3:201     Document Type: Article

References (37)

1. A. Evangelou, G. Kalpouzos, S. Karkabounas, et al., Dose related preventive and therapeutic effects of antioxidants-anticarcinogens on experimentally induced malignant tumors in wistar rats, Cancer Lett. 115, 105-111 (1997).
2. A. Ahmad, K. L. Law, B. Young, et al., Daunorubicin coupled to monoclonal antibodies via a cis-aconitic anhydrate linker: biochemical and cytotoxic properties revisited, Anticancer Res. 10(3), 837-843 (1990).
3. H. E. Kaiser, M. Krenn, B. Bodey, Jr., et al., Growth inhibitors in the treatment of malignant neoplasms, In Vivo 14(5), 287-296 (2000).
4. W. A. Pryor, W. Stahl, and C. L. Rock, Beta carotene: from biochemistry to clinical trials, Nutr. Rev. 58, 39-53 (2000).
5. S. Franceschi, E. Bidoli, E. Negri, et al., Role of macronutrients, vitamins and minerals in the aetiology of squamous carcinoma of the oesophagus, Int. J. Cancer 86(5), 626-631 (2000).
6. S. Franceschi, Nutrients and food groups and large bowel cancer in Europe, Eur. J. Cancer Prev. (Suppl.)1, S49-52 (1999).
7. G. Shklar and S. K. Oh, Experimental basis for cancer prevention by vitamin E, Cancer Invest. 18(3), 214-222 (2000).
8. T. A. Mobio, I. Baudrimont, A. Sanni, et al., Prevention by vitamin E of DNA fragmentation and apoptosis induced by fumonisin B1 in C6 glioma cells, Arch. Toxicol. 74(2), 112-119 (2000).
9. M. S. Alaejos, F. J. Diaz Romero, and C. Diaz Romero, Selenium and cancer: some nutritional aspects, Nutrition 16(5), 376-383 (2000).
10. R. A. Jacob, The role of micronutrients in DNA synthesis and maintenance, Adv. Exp. Med. Biol. 472, 101-103 (1999).
11. R. N. Coffey, R. W. Waston, N. J. Hegarty, et al., Thiol mediated apoptosis in prostate carcinoma cells, Cancer 88(9), 2092-2104 (2000).
12. G. Liu, P. Ghadirian, D. Vesprini, et al., Polymorphism in GSTM1, GSTT1 and CYP1A1 and risk of pancreatic adenocarcinoma, Br. J. Cancer 82(10), 1646-1649 (2000).
13. S. M. Davies, L. L. Robison, J. D. Buckley, et al., Glutathione S-transferase polymorphisms in children with myeloid leukemia, Cancer Epidemiol. Biomarkers Prev. 9(6), 563-566 (2000).
14. C. A. Lang, B. J. Mills, W. Mastopaolo, et al., Blood glutathione decreases in chronic diseases, J. Lab. Clin. Med. 135(5), 402-440 (2000).
15. G. Kallisrtatos and U. Kallistratos, Putrescine as inhibitor of 3,4-benzopyrene carcinogenesis, Eur. J. Cancer 11, 717-728 (1975).
16. H. Sakagami, E. Fujiwara, Y. Yokote, et al., Changes in intracellular concentrations of amino acids and polyamines during the apoptosis of HL-60 cells, Anticancer Res. 20, 265-270 (2000).
17. Y. Yokoyama, J. E. Green, V. P. Sukhatme, et al., Effect of endostatin on spontaneous tumorogenesis of mammary adenicarcinoma in a transgenic mouse model, Cancer Res. 60(16), 4362-4365 (2000).
18. C. E. Cross, M. Traber, J. Eiserich, et al., Micronutrient antioxidants and smoking, Br. Med. Bull. 55(3), 691-704 (1999).
19. A. Ronco, E. De Stefani, P. Baffetta, et al., Vegetables, fruits, and related nutrients and risk of breast cancer: a case study in Uruguay, Nutr. Cancer 35(2), 111-119 (1999).
20. S. Gandini, H. Merzenich, C. Robertson, et al., Meta-analysis of studies on breast cancer risk and diet: the role of fruit and vegetable consumption and the intake of associated micronutrients, Eur. J. Cancer 36(5), 636-646 (2000).
21. A. Cividalli, F. Mauro, E. Livdi, et al., Schedule dependent toxicity and efficacy of combined gemcitabine/paclitaxel treatment in mouse adenocarcinoma, J. Cancer Res. Clin. Oncol. 126(8), 461-467 (2000).
22. S. Cascinu, M. Ligi, E. Del Ferro, et al., Effects of calcium and vitamin supplementation on colon cell proliferation in colorectal cancer, Cancer Invest. 18(50), 411-416 (2000).
23. J. C. Arcos and M. F. Argus, Molecular geometry and carcinogenic activity of aromatic compounds, Adv. Cancer Res. 11, 305-314 (1968).
24. K. Wu, K. J. Helzlsouer, A. J. Alberg, et al., A prospective study of plasma ascorbic acid concentrations and breast cancer, Cancer Causes Control 11(3), 279-283 (2000).
25. H. E. Kaiser, M. Krenn, B. Bodey, Jr., et al., Growth inhibitors in the treatment of malignant neoplasms, In Vivo 14(1), 287-296 (2000).
26. B. Halliwell, The antioxidant paradox, Lancet 355(9210), 1179-1180 (2000).
27. J. U. Schlegel, and G. E. Pipkin, R. Nishimura, et al., The role of ascorbic acid in the prevention of bladder tumor formation, J. Urol. 103, 115-123 (1970).
28. J. M. Price, J. B. Wear, R. R. Brown, et al., Studies on etiology of carcinoma of the urinary bladder, J. Urol. 83, 376-384 (1960).
29. E. Cameron and L. Pauling, Ascorbic acid and the glycosaminoglycans. An orthomolecular approach to cancer and other diseases, Oncology 27, 181-193 (1973).
30. K. Charalabopoulos, S. Karkabounas, V. Papalimneou, et al., Chemical carcinogens and inactivating substances, European Association of Cancer Research (EACR) XVI, p. 100 (2000).
31. W. G. Jaffe, The influence of wheat germ oil on the production of tumors in rats by methylchloranthrene, Exp. Med. Surg. 4, 278-287 (1946).
32. S. Franceschi, Nutrients and food groups and large bowel cancer in Europe, Eur. J. Cancer Prev. 9(1), S49-S52 (1999).
33. 2 (cis-DDP) with guanosine, cytidine, and the aminoacids glycine, L-alanine, L-2-aminobutyric acid, L-norvaline and L-norleucine, Metal Based Drugs 1, 57-63 (1994).
34. 2 with 5′-IMP and 5′-GMP, J. Inorg. Biochem. 72, 133-140 (1998).
35. 3) toxicity and antitumor activity on benzo(a)pyrene treated wistar rats, Metal Ions Biol. Med. 6, 591-593 (2000).
36. K. Charalabopoulos, S. Karkabounas, E. Ioachim, et al., Antitumor and toxic effects on wistar rats of two new platinum complexes, Eur. J. Clin. Invest., 32, 129-133 (2002).
37. T. Magalova, V. Bella, A. Brtkova, et al., Copper, zinc and superoxide dismutase in precancerous, benign diseases, gastric, colorectal and breast cancer, Neoplasma 46(2), 100-104 (1999).